Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 10-1992 | 07-1992 | 04-1992 | 01-1992 | 10-1991 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 2,808 | 3,013 | 2,781 | 2,514 | 2,510 |
| TOTAL | $2,808 | $3,013 | $2,781 | $2,514 | $2,510 |
| Non-Current Assets | |||||
| PPE Net | 8,664 | 8,303 | 7,819 | 7,939 | 7,804 |
| Other Non-Current Assets | 4,459 | 4,616 | 4,670 | 4,741 | 4,796 |
| TOTAL | $13,123 | $12,919 | $12,489 | $12,680 | $12,600 |
| Total Assets | $15,931 | $15,932 | $15,270 | $15,194 | $15,110 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,570 | 2,876 | 3,493 | 3,804 | 3,527 |
| Accrued Expenses | 3,074 | 2,936 | 2,671 | 2,454 | 2,653 |
| TOTAL | $7,617 | $7,161 | $7,448 | $7,452 | $7,398 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 812 | 797 | 782 | 767 | 751 |
| TOTAL | $2,542 | $2,541 | $2,536 | $2,530 | $2,562 |
| Total Liabilities | $10,159 | $9,702 | $9,984 | $9,982 | $9,960 |
| Shareholders' Equity | |||||
| Common Shares | 54 | 54 | 54 | 54 | 54 |
| Other shareholders' equity | -132 | 108 | 488 | -254 | 447 |
| TOTAL | $16,546 | $16,786 | $19,166 | $19,424 | $20,125 |
| Total Liabilities And Equity | $26,705 | $26,488 | $29,150 | $29,406 | $30,085 |